CN101530461B - Traditional Chinese medicine for treating nasopharyngeal cancer - Google Patents
Traditional Chinese medicine for treating nasopharyngeal cancer Download PDFInfo
- Publication number
- CN101530461B CN101530461B CN2008101018365A CN200810101836A CN101530461B CN 101530461 B CN101530461 B CN 101530461B CN 2008101018365 A CN2008101018365 A CN 2008101018365A CN 200810101836 A CN200810101836 A CN 200810101836A CN 101530461 B CN101530461 B CN 101530461B
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- fine powder
- radix
- nasopharyngeal cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention pertains to the field of traditional Chinese medicine for treating tumors and provides a traditional Chinese medicine for treating nasopharyngeal cancer, which is characterized by good curative effect and high efficiency. The traditional Chinese medicine for treating nasopharyngeal cancer is prepared from traditional Chinese medicinal materials including faeces trogopterorum, lacca sinica exsiccate, panax pseudoginseng, selaginella doederleinii hieron, glossy ganoderma, radix sophorae tonkinensis, angelica, rhizoma bolbostemmae, scolopendra and the like, can strengthen the body resistance and consolidate the constitution, benefit Qi and nourish the blood, promote blood circulation to remove blood stasis, clear away heat and toxic materials and fight against cancer, and has the advantages of good curative effect, high efficiency and remarkable result.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment tumor.
Background technology
Treat the field of Chinese medicines of nasopharyngeal carcinoma at present, exist some significantly deficiencies: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect.Many nasopharyngeal carcinoma patients have influenced the time of band tumor existence because of medicine can not effectively suppress throat tumor growth, transfer, diffusion, and patient and family members thereof are satisfied inadequately to this.
To problem set forth above, the present invention provides a kind of Chinese medicine of treating nasopharyngeal carcinoma, and it can solve, and above-mentioned therapeutic effect is obvious inadequately, the slower problem that takes effect, and is effective, instant effect, and it is remarkable to have effect, the advantage of quick result.
Summary of the invention
The present invention realizes through following technical scheme:
A kind of Chinese medicine of treating nasopharyngeal carcinoma is taked raw material of Chinese medicine preparation, fill a prescription into (by weight):
Oletum Trogopterori 0.3-2.5 part Resina Toxicodendri 0.15-1.2 part Radix Notoginseng 0.4-3 part
Herba Selaginellae Doederleinii 0.3-2.5 part Ganoderma 0.4-3 part Radix Sophorae Tonkinensis 0.4-3.2 part
Radix Angelicae Sinensis 0.5-4.2 part Rhizoma Bolbostematis 0.4-3.2 part Scolopendra 0.2-1.8 part
The Chinese medicine of this treatment nasopharyngeal carcinoma is processed by following method:
(1) by above-mentioned weight ratio, Oletum Trogopterori, Herba Selaginellae Doederleinii, Radix Sophorae Tonkinensis, Radix Angelicae Sinensis, Rhizoma Bolbostematis are extracted through conventional water extraction process, process the extractum fine powder;
(2) by above-mentioned weight ratio, Resina Toxicodendri, Radix Notoginseng, Ganoderma, Scolopendra are ground into fine powder respectively, mix, stir with the extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma QI invigorating in the side, the body resistance strengthening and constitution consolidating, tonification the five internal organs; Chinese Angelica blood replonishing is invigorated blood circulation, with the Ganoderma benefiting QI and nourishing blood of associating with, the prosperous hemapodium of gas; Oletum Trogopterori, Radix Notoginseng, Resina Toxicodendri, Herba Selaginellae Doederleinii blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain; Radix Sophorae Tonkinensis, Rhizoma Bolbostematis, Scolopendra heat-clearing and toxic substances removing are anticancer.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating, benefiting QI and nourishing blood, blood circulation promoting and blood stasis dispelling, the anticancer merit of heat-clearing and toxic substances removing altogether, and are effective, instant effect, and it is remarkable to have effect, the advantage of quick result.
The specific embodiment
Through following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Oletum Trogopterori 60 gram Resina Toxicodendri 15 gram Radix Notoginseng 60 grams
Herba Selaginellae Doederleinii 50 kairine sesames 45 Keshan Radix Sophorae Tonkinensis 60 grams
Radix Angelicae Sinensis 80 gram Rhizoma Bolbostematiss 60 gram Scolopendras 20 grams
Press predetermined weight, Oletum Trogopterori, Herba Selaginellae Doederleinii, Radix Sophorae Tonkinensis, Radix Angelicae Sinensis, Rhizoma Bolbostematis are extracted, process extractum fine powder 108.5 grams with conventional water extraction process; Resina Toxicodendri, Radix Notoginseng, Ganoderma, Scolopendra are ground into fine powder respectively, mix, stir with the extractum fine powder; Process fine particle; The capsule of packing into No. 0 is processed 887 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Oletum Trogopterori 180 gram Resina Toxicodendri 60 gram Radix Notoginseng 180 grams
Herba Selaginellae Doederleinii 150 kairine sesames 180 Keshan Radix Sophorae Tonkinensis 60 grams
Radix Angelicae Sinensis 260 gram Rhizoma Bolbostematiss 260 gram Scolopendras 50 grams
By above-mentioned same method, process 2991 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Oletum Trogopterori 250 gram Resina Toxicodendri 120 gram Radix Notoginseng 300 grams
Herba Selaginellae Doederleinii 250 kairine sesames 300 Keshan Radix Sophorae Tonkinensis 320 grams
Radix Angelicae Sinensis 420 gram Rhizoma Bolbostematiss 320 gram Scolopendras 180 grams
By above-mentioned same method, process 5164 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
4.5 parts of 1.5 portions of Radix Notoginseng of 4 parts of Resina Toxicodendri of Oletum Trogopterori
6 parts of 5 parts of Radix Sophorae Tonkinensiss of 4.5 portions of Ganodermas of Herba Selaginellae Doederleinii
3 parts of 8 parts of Scolopendras of 8 parts of Rhizoma Bolbostematiss of Radix Angelicae Sinensis
By above-mentioned same method, process Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
30 parts of 10 portions of Radix Notoginseng of 25 parts of Resina Toxicodendri of Oletum Trogopterori
32 parts of 26 parts of Radix Sophorae Tonkinensiss of 22 portions of Ganodermas of Herba Selaginellae Doederleinii
18 parts of 42 parts of Scolopendras of 42 parts of Rhizoma Bolbostematiss of Radix Angelicae Sinensis
By above-mentioned same method, process Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science nasopharyngeal carcinoma, through 27 routine clinical observations.Selecting the tcm diagnosis nasopharyngeal carcinoma is standard: limb adynamia, and deficient serious, nasal obstruction, nose is painful, nostril stream yellow fluid, CT sees rhino tumor.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 16 examples, women's 11 examples do not have other serious disease, and the age is 44 years old-69 years old, 56.6 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, and limbs are strong, and nasopharynx part is uncomfortable to disappear, and CT sees that rhinopharyngeal neoplasm tumor body dwindles, and newborn tumor is not found at other position.
2, effective: body constitution strengthens, and the nasopharynx part tumor is not seen increase, and newborn tumor is not seen at other position.
3, invalid: the disease no change, nasopharynx part tumor tumor body increases, or newborn tumor is found at other position.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 3 times, each 6 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 3 months after, symptom is obviously improved.27 philtrums of clinical experiment, produce effects 11 people, effective 12 people, invalid 4 people, total effective rate 85.1%.
Claims (1)
1. Chinese medicine of treating nasopharyngeal carcinoma, it is characterized in that: it is processed with the weight ratio of following component, and its component proportioning is:
Oletum Trogopterori 0.3-2.5 part Resina Toxicodendri 0.15-1.2 part Radix Notoginseng 0.4-3 part
Herba Selaginellae Doederleinii 0.3-2.5 part Ganoderma 0.4-3 part Radix Sophorae Tonkinensis 0.4-3.2 part
Radix Angelicae Sinensis 0.5-4.2 part Rhizoma Bolbostematis 0.4-3.2 part Scolopendra 0.2-1.8 part
The Chinese medicine of this treatment nasopharyngeal carcinoma is processed by following method:
(1) by above-mentioned weight ratio, Oletum Trogopterori, Herba Selaginellae Doederleinii, Radix Sophorae Tonkinensis, Radix Angelicae Sinensis, Rhizoma Bolbostematis are extracted through conventional water extraction process, process the extractum fine powder;
(2) by above-mentioned weight ratio, Resina Toxicodendri, Radix Notoginseng, Ganoderma, Scolopendra are ground into fine powder respectively, mix, stir with the extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, Tabules.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101018365A CN101530461B (en) | 2008-03-13 | 2008-03-13 | Traditional Chinese medicine for treating nasopharyngeal cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101018365A CN101530461B (en) | 2008-03-13 | 2008-03-13 | Traditional Chinese medicine for treating nasopharyngeal cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101530461A CN101530461A (en) | 2009-09-16 |
| CN101530461B true CN101530461B (en) | 2012-06-06 |
Family
ID=41101456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008101018365A Expired - Fee Related CN101530461B (en) | 2008-03-13 | 2008-03-13 | Traditional Chinese medicine for treating nasopharyngeal cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101530461B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103055214A (en) * | 2013-01-05 | 2013-04-24 | 马长林 | Traditional Chinese medicine for treating nasopharynx cancer by utilizing lepidogrammitis intermedia |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104644979A (en) * | 2015-03-11 | 2015-05-27 | 王立湖 | Blood-activating and toxin-removing preparation for nasopharyngeal carcinoma and preparation method thereof |
| CN108743813B (en) * | 2018-08-14 | 2021-04-09 | 云南根之然生物科技有限公司 | Traditional Chinese medicine nano-emulsion for resisting nasopharyngeal carcinoma |
| CN108743814A (en) * | 2018-08-14 | 2018-11-06 | 骆漫 | A kind of preparation method of anti-nasopharyngeal carcinoma Chinese medicine composition |
| CN111135214A (en) * | 2020-01-13 | 2020-05-12 | 陈宽兵 | A capsule for treating cancer and its preparation method |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1075086A (en) * | 1993-01-01 | 1993-08-11 | 古模发 | Nasopharyngeal carcinoma mixture and production technology thereof |
| CN1075087A (en) * | 1993-01-01 | 1993-08-11 | 古模发 | Nasopharyngeal carcinoma mixture (II type) and production technology thereof |
| CN1166356A (en) * | 1997-01-13 | 1997-12-03 | 吴荫福 | Medicine powder for nasopharyngeal cancer |
| CN101085132A (en) * | 2007-06-29 | 2007-12-12 | 柴伟利 | Internal-applied traditional Chinese medicine decoction for treating nasopharyngeal cancer |
| CN101104031A (en) * | 2007-06-29 | 2008-01-16 | 李文 | Internal-applied traditional Chinese medicine composition for treating nasopharyngeal cancer |
| CN101129655A (en) * | 2007-09-03 | 2008-02-27 | 于振鹏 | Orally taken traditional Chinese medicine prescription for treating nasopharyngeal carcinoma |
-
2008
- 2008-03-13 CN CN2008101018365A patent/CN101530461B/en not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1075086A (en) * | 1993-01-01 | 1993-08-11 | 古模发 | Nasopharyngeal carcinoma mixture and production technology thereof |
| CN1075087A (en) * | 1993-01-01 | 1993-08-11 | 古模发 | Nasopharyngeal carcinoma mixture (II type) and production technology thereof |
| CN1166356A (en) * | 1997-01-13 | 1997-12-03 | 吴荫福 | Medicine powder for nasopharyngeal cancer |
| CN101085132A (en) * | 2007-06-29 | 2007-12-12 | 柴伟利 | Internal-applied traditional Chinese medicine decoction for treating nasopharyngeal cancer |
| CN101104031A (en) * | 2007-06-29 | 2008-01-16 | 李文 | Internal-applied traditional Chinese medicine composition for treating nasopharyngeal cancer |
| CN101129655A (en) * | 2007-09-03 | 2008-02-27 | 于振鹏 | Orally taken traditional Chinese medicine prescription for treating nasopharyngeal carcinoma |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103055214A (en) * | 2013-01-05 | 2013-04-24 | 马长林 | Traditional Chinese medicine for treating nasopharynx cancer by utilizing lepidogrammitis intermedia |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101530461A (en) | 2009-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101530461B (en) | Traditional Chinese medicine for treating nasopharyngeal cancer | |
| CN101530508B (en) | Traditional Chinese medicine for treating ovarian cancer | |
| CN101518611B (en) | Traditional Chinese medicine for treating bone tumor | |
| CN101530490B (en) | Traditional Chinese medicine for treating bladder cancer | |
| CN101843829B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101537114B (en) | Chinese medicine for treating arrhythmia | |
| CN101406566A (en) | Chinese medicine for treating gastric cancer | |
| CN101518633B (en) | Traditional Chinese medicine for treating thyroid cancer | |
| CN101850017B (en) | Chinese medicament for treating asthma | |
| CN101537061B (en) | Chinese medicine for treating liver cancer | |
| CN101537068B (en) | Chinese medicine for treating angina | |
| CN101843825B (en) | Chinese medicament for treating climacteric syndromes | |
| CN101843705B (en) | Chinese medicament for treating lupus erythematosus | |
| CN101850018A (en) | Chinese medicament for treating cervical spondylosis | |
| CN101843718B (en) | Chinese medicament for treating lupus erythematosus | |
| CN101554426B (en) | Traditional Chinese medicine for treating diabetic obstipation | |
| CN101850022B (en) | Anti-infective Chinese medicament | |
| CN101884704B (en) | Traditional Chinese medicine for treating asthma | |
| CN101850079B (en) | Chinese medicament for treating asthma | |
| CN101850014B (en) | Chinese medicament for treating asthma | |
| CN101879246A (en) | Traditional Chinese medicine for treating lupus erythematosus | |
| CN101879259B (en) | Traditional Chinese medicine for treating pulmonary heart diseases | |
| CN101843797A (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101518587A (en) | Traditional Chinese medicine for treating laryngeal carcinoma | |
| CN101537157A (en) | Chinese medicine for treating esophagus cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: RUGAO GRINDING HEAD CONSTRUCTION DEVELOPMENT CO., Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20130809 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 226500 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20130809 Address after: 226500 Guangming West Road, grinding head town, Rugao, Jiangsu Patentee after: Rugao grinding head Construction Development Co Ltd Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 Building 10 room 602 Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120606 Termination date: 20190313 |